FIELD: medicinal industry, pharmacy.
SUBSTANCE: invention relates to a spasmolytic medicinal agent comprising drotaverine hydrochloride used for arresting smooth muscle spasm. Agent comprises the following components, wt.-%: drotaverine hydrochloride, 15.0-62.5; inert pharmaceutical vehicle, 28.1-84.696; binding agent, 0.1-7.0; stearic acid and/or stearate, 0.2-1.0; inorganic acid, 0.004-1.4. Agent comprises phosphoric or hydrochloric acid as an inorganic acid. Agent is made as a tablet, its mass is from 0.065 to 0.26 g. Drotaverine hydrochloride tablets are stable in the making process and in storing for 2 years. Quality of tablets satisfies Pharmacopoeia requirements.
EFFECT: improved and valuable pharmaceutical and medicinal properties of agent.
6 cl, 1 dwg, 5 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR OBTAINING SPASMOLYTIC MEDICINAL PREPARATION | 2003 |
|
RU2252024C2 |
| METHOD FOR PREPARING ANTIBACTERIAL MEDICINAL AGENT | 2002 |
|
RU2224517C1 |
| PHARMACEUTICAL COMPOSITION SHOWING SPASMOLYTIC ACTIVITY, METHOD OF ITS PREPARING | 2001 |
|
RU2183119C1 |
| PHARMACEUTICAL COMPOSITION SHOWING ANALGETIC, ANTI-INFLAMMATORY, ANTIPYRETIC AND SPASMOLYTIC EFFECT | 2001 |
|
RU2183116C1 |
| DOSAGE FORM FOR RELEASING DROTAVERINE IN ORAL CAVITY | 2019 |
|
RU2729659C1 |
| METHOD OF ANTIANGINAL MEDICINAL AGENT PREPARING | 2000 |
|
RU2195932C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING URINARY DISTURBANCES | 2012 |
|
RU2497504C1 |
| COMPOSITION - DRUG OF ANTIARTHROSIS AGENT GLUCOSEAMINE HYDROCHLORIDE FOR ORAL ADMINISTRATION | 1996 |
|
RU2130310C1 |
| VITAMIN-PREBIOTIC IMMUNOSTIMULATING AGENT | 2020 |
|
RU2747780C1 |
| METHOD FOR PREPARING SOLID MEDICINAL FORMULATION COMPRISING GLUCOSAMINE HYDROCHLORIDE | 2003 |
|
RU2247563C1 |
